In people with comorbidities; and what Phone Number List differences there are between the main candidates (which is essential for the design of effective vaccination strategies). Furthermore, the process of distributing vaccines continues to be dominated by national interests (particularly those of developed countries). Although the Global Access Fund Phone Number List for Covid-19 Vaccines ( COVAX) is a great advance, it loses effectiveness in the face of huge bilateral advance purchase agreements from rich countries that can afford to bet on several vaccines. For example, high-income countries have already purchased about 80% of the doses that are Phone Number List available in the first year.
In short, rich countries have Phone Number List appropriated 3.8 billion doses from different manufacturers, against 3.2 billion including some 700 million doses for COVA for the rest of the world. In other words, they reserved enough doses to cover their populations several times, with the possibility that the remaining Phone Number List doses will not be enough to vaccinate even the most vulnerable groups in other countries. At the same time, as the race for vaccines is focused mainly on Western markets, some candidates would be very unlikely to be viable outside of a developed country. The one from ust be stored at -70 °C, a temperature lower than that of the Antarctic Phone Number List winter. The distribution of this vaccine will create costly and complex logistical challenges, especially for low- and middle-income countries.
Although other candidates Phone Number List eg AstraZeneca-Oxford are stable at higher temperatures, it is notable that the first product to reach the approval stage includes such an overt element of market discrimination. Beyond national interests lurks the problem of even narrower private interests, the product of a hyper-financialized pharmaceutical innovation Phone Number List model. Now that the pandemic gives investors the chance of a windfall, the industry is expanding the business model to develop future vaccines. But while investors are profiting from soaring Phone Number List stocks and surging capital gains and